Children and adults with myotonia manifest the same skeletal muscle ion-channel pathophysiology, but pediatric evidence for antimyotonic treatment is limited. A paediatric investigation plan (PIP) is investigating mexiletine's safety, pharmacokinetics (PK), and effectiveness to confirm posology.
No takes yet. Share an insight, caveat, or question.
Barnérias et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: